Financhill
Sell
31

OKLO Quote, Financials, Valuation and Earnings

Last price:
$21.49
Seasonality move :
2.32%
Day range:
$19.65 - $22.67
52-week range:
$5.35 - $28.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
11.18x
Volume:
19.6M
Avg. volume:
16.2M
1-year change:
102.45%
Market cap:
$2.9B
Revenue:
--
EPS (TTM):
-$5.36
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $2.5M $6M
Selling, General & Admin -- -- -- $2.7M $4M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $5.2M $10M
Operating Income -- -- -- -$5.2M -$10M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$5.2M -$10M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$5.2M -$10M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$5.2M -$10M
 
Basic EPS (Cont. Ops) -- -- -- -$0.04 -$0.08
Diluted EPS (Cont. Ops) -- -- -- -$0.04 -$0.08
Weighted Average Basic Share -- -- -- $122.1M $122.1M
Weighted Average Diluted Share -- -- -- $122.1M $122.1M
 
EBITDA -- -- -- -$5.2M -$10M
EBIT -- -- -- -$5.2M -$10M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$5.2M -$10M
Operating Income (Adjusted) -- -- -- -$5.2M -$10M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $1.7M $5M
Selling, General & Admin -- -- -- $3M $7.2M
Other Inc / (Exp) -- -- -- -$4.1M --
Operating Expenses -- -- -- $4.7M $12.3M
Operating Income -- -- -- -$4.7M -$12.3M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$8.7M -$9.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $225K
Net Income to Company -- -- -- -$17.9M -$63.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$8.7M -$10M
 
Basic EPS (Cont. Ops) -- -- -- -$0.07 -$0.08
Diluted EPS (Cont. Ops) -- -- -- -$0.07 -$0.08
Weighted Average Basic Share -- -- -- $122.1M $122.1M
Weighted Average Diluted Share -- -- -- $122.1M $122.1M
 
EBITDA -- -- -- -$4.7M -$12.2M
EBIT -- -- -- -$4.7M -$12.3M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -$4.7M -$12.3M
Operating Income (Adjusted) -- -- -- -$4.7M -$12.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- $19.3M
Selling, General & Admin -- -- -- -- $18.8M
Other Inc / (Exp) -- -- -- -$5.2M -$18.3M
Operating Expenses -- -- -- -- $38.1M
Operating Income -- -- -- -- -$38.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- -$52.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $388.6K
Net Income to Company -- -- -- -- -$143.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- -$52.4M
 
Basic EPS (Cont. Ops) -- -- -- -- -$5.36
Diluted EPS (Cont. Ops) -- -- -- -- -$5.36
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- -$38M
EBIT -- -- -- -- -$38.1M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- -$38.1M
Operating Income (Adjusted) -- -- -- -- -$38.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- $1.4M $3.5M $15.8M
Selling, General & Admin -- -- $975.9K $4.5M $14.3M
Other Inc / (Exp) -- -- -- -$5.2M -$13.1M
Operating Expenses -- -- $2.4M $8M $30.1M
Operating Income -- -- -$2.4M -$8M -$30.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -$2.4M -$13.1M -$38.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $388.6K
Net Income to Company -- -- -$4.2M -$27M -$116.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$2.4M -$13.1M -$39.3M
 
Basic EPS (Cont. Ops) -- -- -$0.02 -$0.11 -$5.25
Diluted EPS (Cont. Ops) -- -- -$0.02 -$0.11 -$5.25
Weighted Average Basic Share -- -- $122.1M $244.2M $222.2M
Weighted Average Diluted Share -- -- $122.1M $244.2M $222.2M
 
EBITDA -- -- -$2.4M -$8M -$30M
EBIT -- -- -$2.4M -$8M -$30.1M
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -$2.4M -$8M -$30.1M
Operating Income (Adjusted) -- -- -$2.4M -$8M -$30.1M
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Cash and Equivalents -- -- -- $10.4M $9.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- $9.7K $279.4K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $10.5M $10.5M
 
Property Plant And Equipment -- -- -- $502.2K $447.9K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- $85.5K $51.3K
Total Assets -- -- -- $11M $11M
 
Accounts Payable -- -- -- $99.9K $336.6K
Accrued Expenses -- -- -- $147.1K $87.2K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- $190.1K $210.3K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $437.2K $634K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $29.8M $39.1M
 
Common Stock -- -- -- $460 $480
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -$18.7M -$28.1M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -$18.7M -$28.1M
 
Total Liabilities and Equity -- -- -- $11M $11M
Cash and Short Terms -- -- -- $10.4M $9.7M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- -- $91.8M
Short Term Investments -- -- -- -- $139.6M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $2.2M
Other Current Assets -- -- -- -- $56.4K
Total Current Assets -- -- -- -- $234.8M
 
Property Plant And Equipment -- -- -- -- $1.8M
Long-Term Investments -- -- -- -- $57.1M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- $115K
Total Assets -- -- -- -- $293.8M
 
Accounts Payable -- -- -- -- $361.2K
Accrued Expenses -- -- -- -- $1.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- $466.6K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- -- $4.8M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $30.5M
 
Common Stock -- -- -- -- $12.2K
Other Common Equity Adj -- -- -- -- $2.7M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -- $263.3M
 
Total Liabilities and Equity -- -- -- -- $293.8M
Cash and Short Terms -- -- -- -- $231.4M
Total Debt -- -- -- -- --
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Net Income to Stockholders -- -- -- -$5.2M -$10M
Depreciation & Amoritzation -- -- -- $2.6K $29.5K
Stock-Based Compensation -- -- -- $124.7K $288.3K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$5.5M -$10M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$59.8K -$149.6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $4M $9M
Cash From Financing -- -- -- $4.2M $9.4M
 
Beginning Cash (CF) -- -- -- $11.9M $10.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -$1.4M -$790.4K
Ending Cash (CF) -- -- -- $10.4M $9.7M
 
Levered Free Cash Flow -- -- -- -$5.6M -$10.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$17.9M -$63.3M
Depreciation & Amoritzation -- -- -- $36.5K $180.4K
Stock-Based Compensation -- -- -- $144.2K $10.8M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$10.4M -$24.9M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$60.1K -$194M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $10.8M $300.4M
Cash From Financing -- -- -- $10.8M $300.8M
 
Beginning Cash (CF) -- -- -- $9.7M $9.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $356.4K $81.9M
Ending Cash (CF) -- -- -- $10M $91.8M
 
Levered Free Cash Flow -- -- -- -$10.4M -$25.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -- -$143.7M
Depreciation & Amoritzation -- -- -- -- $352K
Stock-Based Compensation -- -- -- $359.6K $20.1M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- -$59.2M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$382.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- $614.2M
Cash From Financing -- -- -- -- $615.1M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- $173.5M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- -$59.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -$4.2M -$27M -$116.7M
Depreciation & Amoritzation -- -- $11.1K $59.9K $292.1K
Stock-Based Compensation -- -- $118.7K $241K $19.9M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -$4.2M -$17.2M -$42M
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$86.3K -$85.5K -$382.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $13M $601.2M
Cash From Financing -- -- $8.4K $13.1M $602M
 
Beginning Cash (CF) -- -- $10.4M $19.3M $19.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$4.3M -$4.2M $177.7M
Ending Cash (CF) -- -- $6.1M $15.1M $197.5M
 
Levered Free Cash Flow -- -- -$4.3M -$17.3M -$42.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock